Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.

导出 OA

翻译打印收藏纠错

第一作者： Akihiko,Nishikimi

第一单位： Biosafety Division, Research Institute, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi 474-8511, Japan. Electronic address: a-nishikimi@ncgg.go.jp.

作者： Akihiko,Nishikimi ^[1] ; Ken,Watanabe ^[2] ; Atsushi,Watanabe ^[3] ; Mikako,Yasuoka ^[4] ; Ryota,Watanabe ^[4] ; Hironori,Oshima ^[5] ; Yuichi,Kitagawa ^[6] ; Haruhiko,Tokuda ^[7] ; Shumpei,Niida ^[8] ; Masayo,Kojima ^[4]

作者单位： Biosafety Division, Research Institute, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi 474-8511, Japan. Electronic address: a-nishikimi@ncgg.go.jp. ^[1] Bioresource Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan; Department of Musculoskeletal Disease, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[2] Communal Laboratory, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[3] Department of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[4] Department of Clinical Laboratory, Hospital, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[5] Department of Infection Control, Hospital, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[6] Bioresource Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan; Department of Clinical Laboratory, Hospital, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[7] Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan. ^[8]